Cargando…
Oral Anticoagulation in Patients with Chronic Liver Disease
The administration of an anticoagulant in patients with liver disease (nonalcoholic steatohepatitis—NASH, nonalcoholic fatty liver disease—NAFLD, chronic hepatitis, or cirrhosis) who have an indication (atrial fibrillation, venous thrombosis, or pulmonary embolism) is challenging because there is an...
Autores principales: | Costache, Raluca S., Dragomirică, Andreea S., Gheorghe, Bogdan E., Balaban, Vasile D., Stanciu, Silviu M., Jinga, Mariana, Costache, Daniel O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967228/ https://www.ncbi.nlm.nih.gov/pubmed/36837547 http://dx.doi.org/10.3390/medicina59020346 |
Ejemplares similares
-
Ratio of Spleen Diameter to Red Blood Cell Distribution Width: A Novel Indicator for Celiac Disease
por: Balaban, Daniel Vasile, et al.
Publicado: (2015) -
Metastatic Renal Cell Carcinoma to Pancreas: Case Series and Review of the Literature
por: Balaban, Daniel Vasile, et al.
Publicado: (2023) -
Cutaneous Manifestations in Pancreatic Diseases—A Review
por: Miulescu, Raluca, et al.
Publicado: (2020) -
Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022) -
An Overview on Primary Sclerosing Cholangitis
por: Vlăduţ, Cătălina, et al.
Publicado: (2020)